Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab over 52 Weeks

Main Article Content

Desiree van der Heijde
Masato Okada
Chin Lee
Catherine L Shuler
Suchitrita Rathmann
Chen-Yen Lin
David Amato
Philip J Mease


psoriasis, psoriatic arthritis, ixekizumab, biologic therapy


Abstract not available.


Disclosures: Study sponsored by Eli Lilly and Company.


Copyright 2018 SKIN